发明授权
US07592358B2 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
有权
具有MCH拮抗活性的炔烃化合物和包含这些化合物的药物
- 专利标题： Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
- 专利标题（中）： 具有MCH拮抗活性的炔烃化合物和包含这些化合物的药物
-
申请号： US11104889申请日： 2005-04-13
-
公开(公告)号： US07592358B2公开(公告)日： 2009-09-22
- 发明人: Dirk Stenkamp , Stephan Georg Mueller , Philipp Lustenberger , Thorsten Lehmann-Lintz , Gerald Juergen Roth , Klaus Rudolf , Marcus Schindler , Leo Thomas , Ralf Lotz
- 申请人： Dirk Stenkamp , Stephan Georg Mueller , Philipp Lustenberger , Thorsten Lehmann-Lintz , Gerald Juergen Roth , Klaus Rudolf , Marcus Schindler , Leo Thomas , Ralf Lotz
- 申请人地址： DE Ingelheim
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim
- 代理商 Michael P. Morris; Mary-Ellen M. Devlin; Timothy X. Witkowski
- 主分类号： A61K31/47
- IPC分类号： A61K31/47 ; A61K31/44 ; A61K31/445 ; C07D211/68 ; C07D215/00 ; C07D401/00
摘要：
Alkyne compounds having MCH-receptor antagonistic activity, which are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.